MOLECULAR CHARACTERIZATION OF EXTRANODAL NATURAL KILLER (NK)/T‐CELL LYMPHOMAS, NASAL TYPE FROM LATIN AMERICA
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2437_115
Abstract: clinical trial is still ongoing (ClinicalTrials.gov, NCT 2085655). Furthermore, promising response of single agent, chidamide, a new oral HDAC inhibitor, for the treatment of relapsed or refractory NK/ TCL without significant EBV‐reactivation was recently observed… read more here.
Keywords: molecular characterization; killer cell; characterization extranodal; cell lymphomas ... See more keywords